Baby KJ's medical team plans to ask the FDA to approve a clinical trial for a pioneering gene editing approach this winter.
The trial would be open to patients with seven different urea cycle disorders.
“This is what we thought we would never get,”
Kyle Muldoon, Baby KJ's father, expressed his emotions while watching a football game with his son.
Autor's resume: Baby KJ's medical team seeks FDA approval for gene editing trial.